{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-26-000003","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2026-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.647085+00:00","generated_at":"2026-05-16T11:48:51.994448+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"confidence":"high","headline":"Salarius shareholders re-elect directors, approve executive compensation, ratify EY as auditor","bullets":["Votes for Hanish: 143,525; against: 11,932; abstain: 5,761; broker non-votes: 256,225.","Votes for McVicar: 143,599; against: 10,058; abstain: 7,561; broker non-votes: 256,225.","Advisory vote on executive compensation approved: 132,240 for, 22,606 against, 6,372 abstentions; broker non-votes: 256,225.","Ratification of Ernst & Young LLP as auditor: 401,439 for, 12,132 against, 3,872 abstentions.","Quorum achieved: 417,443 shares present (39.7% of 1,051,782 outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-26-000003","json":"https://secwatch.observer/filing/0001615219-26-000003.json","markdown":"https://secwatch.observer/filing/0001615219-26-000003.md","text":"https://secwatch.observer/filing/0001615219-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/0001615219-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/flks-20251231.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:48:51.994448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}